Kristina Leslie Sells 2,187 Shares of Hinge Health (NYSE:HNGE) Stock

Hinge Health Inc. (NYSE:HNGE) Director Kristina Leslie sold 2,187 shares of the business’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $40.46, for a total transaction of $88,486.02. Following the sale, the director owned 32,813 shares in the company, valued at $1,327,613.98. This trade represents a 6.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Hinge Health Stock Performance

Shares of NYSE HNGE traded up $3.63 during midday trading on Wednesday, hitting $44.25. The company’s stock had a trading volume of 5,591,654 shares, compared to its average volume of 1,161,845. The company’s fifty day moving average price is $50.45. Hinge Health Inc. has a 1 year low of $33.42 and a 1 year high of $62.18.

Hinge Health (NYSE:HNGE) last announced its earnings results on Tuesday, November 4th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.18. The business had revenue of $154.21 million for the quarter, compared to analysts’ expectations of $142.44 million. The firm’s quarterly revenue was up 53.3% on a year-over-year basis. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health announced that its board has authorized a share repurchase program on Wednesday, November 12th that authorizes the company to buyback $250.00 million in outstanding shares. This buyback authorization authorizes the company to reacquire up to 7.2% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s management believes its shares are undervalued.

Institutional Trading of Hinge Health

A number of institutional investors have recently bought and sold shares of the business. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Hinge Health in the 3rd quarter valued at about $37,000. Montag A & Associates Inc. purchased a new stake in Hinge Health during the second quarter worth approximately $41,000. SBI Securities Co. Ltd. acquired a new position in Hinge Health in the second quarter valued at approximately $48,000. Aster Capital Management DIFC Ltd purchased a new position in Hinge Health in the third quarter valued at approximately $49,000. Finally, Jones Financial Companies Lllp raised its holdings in Hinge Health by 348.0% during the third quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock worth $54,000 after purchasing an additional 870 shares in the last quarter.

Analyst Upgrades and Downgrades

HNGE has been the topic of several analyst reports. Canaccord Genuity Group increased their price objective on Hinge Health from $61.00 to $65.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Stifel Nicolaus upped their price target on Hinge Health from $63.00 to $66.00 and gave the stock a “buy” rating in a report on Thursday, September 11th. Barclays lifted their price objective on Hinge Health from $62.00 to $65.00 and gave the company an “overweight” rating in a research note on Wednesday, November 5th. Weiss Ratings reissued a “sell (d)” rating on shares of Hinge Health in a research report on Wednesday, October 8th. Finally, Morgan Stanley raised their target price on shares of Hinge Health from $57.00 to $67.00 and gave the company an “overweight” rating in a report on Tuesday, September 23rd. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Hinge Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $59.93.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.